6161 - 6170 of 6295 Results
Title
Year
- Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial2024OPENTitle: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 69Issue #:Start Page: 102474End Page: 102474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474Best OA location URL: http://www.thelancet.com/article/S2589537024000531/pdfCitation Count: 18
-
OPENTitle: Automated Deep Brain Stimulation Programming for TremorJournal Name: IEEE Transactions on Neural Systems and Rehabilitation EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 26Issue #: 8Start Page: 1618End Page: 1625Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1109/tnsre.2018.2852222Best OA location URL: https://doi.org/10.1109/tnsre.2018.2852222Citation Count: 38
- Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein2021OPENTitle: Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synucleinJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01283-7Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-021-01283-7Citation Count: 21
-
OPENTitle: Decision-Making Deficits Associated with Amyloidosis in Lewy Body DisordersJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2016.00693Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2016.00693/pdfCitation Count: 3
- Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis2021OPENTitle: Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease PsychosisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.633645Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.633645/pdfCitation Count: 7
- Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.2022OPENTitle: Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 4Start Page: 266End Page: 278Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1037/neu0000795Best OA location URL: https://psyarxiv.com/zvqge/downloadCitation Count: 5
-
OPENTitle: RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursorsJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 223Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202307092Best OA location URL: https://rupress.org/jcb/article-pdf/223/6/e202307092/1926155/jcb_202307092.pdfCitation Count: 10
-
OPENTitle: TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s diseaseJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 215Issue #: 9Start Page: 2247End Page: 2264Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20180484Best OA location URL: https://rupress.org/jem/article-pdf/215/9/2247/1171465/jem_20180484.pdfCitation Count: 66
- Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)2022OPENTitle: Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)Journal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-022-06160-9Best OA location URL: https://trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-022-06160-9Citation Count: 7
- Understanding the relationship between freezing of gait and other progressive supranuclear palsy features2020OPENTitle: Understanding the relationship between freezing of gait and other progressive supranuclear palsy featuresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 78Issue #:Start Page: 56End Page: 60Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.07.009Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.07.009Citation Count: 9